282 related articles for article (PubMed ID: 31471752)
1. Clinical evaluation of in silico planning and real-time simulation of hepatic radiofrequency ablation (ClinicIMPPACT Trial).
Moche M; Busse H; Futterer JJ; Hinestrosa CA; Seider D; Brandmaier P; Kolesnik M; Jenniskens S; Blanco Sequeiros R; Komar G; Pollari M; Eibisberger M; Portugaller HR; Voglreiter P; Flanagan R; Mariappan P; Reinhardt M
Eur Radiol; 2020 Feb; 30(2):934-942. PubMed ID: 31471752
[TBL] [Abstract][Full Text] [Related]
2. Transarterial chemoembolization plus multi-imaging-guided radiofrequency ablation for elimination of hepatocellular carcinoma nodules measuring 3.1 to 5.0 cm: a single-center study.
Haochen W; Jian W; Li S; Tianshi L; Xiaoqiang T; Yinghua Z
J Int Med Res; 2018 Jul; 46(7):2650-2657. PubMed ID: 29683022
[TBL] [Abstract][Full Text] [Related]
3. Quantitative evaluation of CT-perfusion map as indicator of tumor response to transarterial chemoembolization and radiofrequency ablation in HCC patients.
Ippolito D; Fior D; Bonaffini PA; Capraro C; Leni D; Corso R; Sironi S
Eur J Radiol; 2014 Sep; 83(9):1665-71. PubMed ID: 24962900
[TBL] [Abstract][Full Text] [Related]
4. A prospective development study of software-guided radio-frequency ablation of primary and secondary liver tumors: Clinical intervention modelling, planning and proof for ablation cancer treatment (ClinicIMPPACT).
Reinhardt M; Brandmaier P; Seider D; Kolesnik M; Jenniskens S; Sequeiros RB; Eibisberger M; Voglreiter P; Flanagan R; Mariappan P; Busse H; Moche M;
Contemp Clin Trials Commun; 2017 Dec; 8():25-32. PubMed ID: 29696193
[TBL] [Abstract][Full Text] [Related]
5. Software-based planning of ultrasound and CT-guided percutaneous radiofrequency ablation in hepatic tumors.
van Amerongen MJ; Mariappan P; Voglreiter P; Flanagan R; Jenniskens SFM; Pollari M; Kolesnik M; Moche M; Fütterer JJ
Int J Comput Assist Radiol Surg; 2021 Jun; 16(6):1051-1057. PubMed ID: 33974224
[TBL] [Abstract][Full Text] [Related]
6. Combined transarterial chemoembolization and radiofrequency ablation for small treatment-naïve hepatocellular carcinoma infeasible for ultrasound-guided radiofrequency ablation: long-term outcomes.
Hyun D; Cho SK; Shin SW; Park KB; Lee SY; Park HS; Do YS
Acta Radiol; 2018 Jul; 59(7):773-781. PubMed ID: 29034691
[TBL] [Abstract][Full Text] [Related]
7. Value of Nonrigid Registration of Pre-Procedure MR with Post-Procedure CT After Radiofrequency Ablation for Hepatocellular Carcinoma.
Park J; Lee JM; Lee DH; Joo I; Yoon JH; Park JY; Klotz E
Cardiovasc Intervent Radiol; 2017 Jun; 40(6):873-883. PubMed ID: 28091728
[TBL] [Abstract][Full Text] [Related]
8. Postablation assessment using follow-up registration of CT images before and after radiofrequency ablation (RFA): prospective evaluation of midterm therapeutic results of RFA for hepatocellular carcinoma.
Shin S; Lee JM; Kim KW; Joo I; Han JK; Choi BI; Klotz E
AJR Am J Roentgenol; 2014 Jul; 203(1):70-7. PubMed ID: 24951197
[TBL] [Abstract][Full Text] [Related]
9. Radiofrequency ablation of hepatocellular carcinoma guided by real-time physics-based ablation simulation: a prospective study.
Hoffer EK; Drinane MC; Bhatnagar V; Mehta R; Munger DP; Borsic A
Int J Hyperthermia; 2024; 41(1):2331704. PubMed ID: 38503326
[TBL] [Abstract][Full Text] [Related]
10. Hypertonic saline-enhanced radiofrequency versus chemoembolization sequential radiofrequency in the treatment of large hepatocellular carcinoma.
El-Kady NM; Esmat G; Mahmoud EH; Darweesh SK; Mahmoud SH; Elagawy WA
Eur J Gastroenterol Hepatol; 2013 May; 25(5):628-33. PubMed ID: 23325283
[TBL] [Abstract][Full Text] [Related]
11. Safety margin for CT- and US-guided radiofrequency ablation after TACE of HCC in the hepatic dome.
Mitani H; Naito A; Chosa K; Kodama H; Sumida M; Moriya T; Awai K
Minim Invasive Ther Allied Technol; 2022 Aug; 31(6):894-901. PubMed ID: 34726557
[TBL] [Abstract][Full Text] [Related]
12. [Clinical application of ultrasound-guided radiofrequency ablation for primary hepatocellular carcinoma near the liver surface].
Wu J; Lin S; Wu W; Yan K; Dai Q; Chen M
Zhonghua Zhong Liu Za Zhi; 2015 Dec; 37(12):933-7. PubMed ID: 26887624
[TBL] [Abstract][Full Text] [Related]
13. The relationship between applied energy and ablation zone volume in patients with hepatocellular carcinoma and colorectal liver metastasis.
Heerink WJ; Solouki AM; Vliegenthart R; Ruiter SJS; Sieders E; Oudkerk M; de Jong KP
Eur Radiol; 2018 Aug; 28(8):3228-3236. PubMed ID: 29536242
[TBL] [Abstract][Full Text] [Related]
14. CT Perfusion for Early Response Evaluation of Radiofrequency Ablation of Focal Liver Lesions: First Experience.
Marquez HP; Puippe G; Mathew RP; Alkadhi H; Pfammatter T; Fischer MA
Cardiovasc Intervent Radiol; 2017 Jan; 40(1):90-98. PubMed ID: 27812781
[TBL] [Abstract][Full Text] [Related]
15. Value or waste: Perfusion imaging following radiofrequency ablation - early experience.
Thieme SF; Vahldiek JL; Tummler K; Poch F; Gemeinhardt O; Hiebl B; Lehmann KS; Hamm B; Niehues SM
Clin Hemorheol Microcirc; 2015; 61(2):323-31. PubMed ID: 26410879
[TBL] [Abstract][Full Text] [Related]
16. Central lower attenuating lesion in the ablation zone on immediate follow-up CT after percutaneous radiofrequency ablation for hepatocellular carcinoma: incidence and clinical significance.
Park Y; Choi D; Rhim H; Kim YS; Lee JY; Chang I; Lim HK; Park CK
Eur J Radiol; 2010 Sep; 75(3):391-6. PubMed ID: 19467813
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Small Hepatocellular Carcinoma (≤2 cm) in the Caudate Lobe with Sequential Transcatheter Arterial Chemoembolization and Radiofrequency Ablation.
Hyun D; Cho SK; Shin SW; Rhim H; Koh KC; Paik SW
Cardiovasc Intervent Radiol; 2016 Jul; 39(7):1015-22. PubMed ID: 26975761
[TBL] [Abstract][Full Text] [Related]
18. 3D CACT-assisted Radiofrequency Ablation Following Transarterial Chemoembolization for Hepatocellular Carcinoma: Early Experience.
Jiao DC; Han XW; Wu G; Ren JZ
Asian Pac J Cancer Prev; 2015; 16(17):7897-903. PubMed ID: 26625818
[TBL] [Abstract][Full Text] [Related]
19. Radiofrequency ablation of liver metastases-software-assisted evaluation of the ablation zone in MDCT: tumor-free follow-up versus local recurrent disease.
Keil S; Bruners P; Schiffl K; Sedlmair M; Mühlenbruch G; Günther RW; Das M; Mahnken AH
Cardiovasc Intervent Radiol; 2010 Apr; 33(2):297-306. PubMed ID: 19688366
[TBL] [Abstract][Full Text] [Related]
20. Ultrasound-ultrasound image overlay fusion improves real-time control of radiofrequency ablation margin in the treatment of hepatocellular carcinoma.
Minami Y; Minami T; Hagiwara S; Ida H; Ueshima K; Nishida N; Murakami T; Kudo M
Eur Radiol; 2018 May; 28(5):1986-1993. PubMed ID: 29196855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
